Cargando…
Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin
BACKGROUND: Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a newly discovered oncogene. It is an active cell proliferation regulatory factor that inhibits tumor apoptosis in gastric cancer (GC) cells. CIP2A is functionally related to chemoresistance in various types of tumors according to...
Autores principales: | Zhao, Yong-Xun, Ma, Li-Bin, Yang, Ze, Wang, Fang, Wang, Hui-Ying, Dang, Jia-Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994047/ https://www.ncbi.nlm.nih.gov/pubmed/36908323 http://dx.doi.org/10.4251/wjgo.v15.i2.286 |
Ejemplares similares
-
Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy
por: Miao, You-Han, et al.
Publicado: (2021) -
Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression
por: Liu, Li-Ping, et al.
Publicado: (2018) -
Use of the alkaline phosphatase to prealbumin ratio as an independent predictive factor for the prognosis of gastric cancer
por: Li, Yang, et al.
Publicado: (2020) -
miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway
por: Sun, Chen, et al.
Publicado: (2017) -
Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer
por: Amnekar, Ramchandra Vigay, et al.
Publicado: (2020)